HM Payson & Co. Has $1.19 Million Holdings in GE HealthCare Technologies Inc. $GEHC

HM Payson & Co. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 32.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,863 shares of the company’s stock after selling 7,461 shares during the quarter. HM Payson & Co.’s holdings in GE HealthCare Technologies were worth $1,191,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Allianz SE raised its position in GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after buying an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. bought a new position in shares of GE HealthCare Technologies during the 2nd quarter worth approximately $34,000. Game Plan Financial Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 295.3% in the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after purchasing an additional 375 shares during the last quarter. N.E.W. Advisory Services LLC lifted its position in shares of GE HealthCare Technologies by 75.2% in the second quarter. N.E.W. Advisory Services LLC now owns 545 shares of the company’s stock worth $40,000 after purchasing an additional 234 shares in the last quarter. Finally, HFM Investment Advisors LLC acquired a new position in GE HealthCare Technologies during the first quarter worth $60,000. 82.06% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have issued reports on GEHC. Citigroup lifted their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research report on Thursday, October 30th. Jefferies Financial Group increased their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 22nd. Finally, BTIG Research reiterated a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $87.09.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $83.15 on Tuesday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The business’s 50 day moving average price is $78.89 and its two-hundred day moving average price is $75.91. The company has a market cap of $37.88 billion, a PE ratio of 17.18, a price-to-earnings-growth ratio of 3.49 and a beta of 1.09. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s payout ratio is currently 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.